Medtronic (NYSE:MDT) will report earnings before markets open on Tuesday, May 21st. Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
Here is your Cheat Sheet to Medtronic Earnings:
Earnings Expectations: Analysts expect earnings of $1.03 per share on revenues of $4.39 billion. Currently, the company’s P/E ratio stands at 14.76.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.91 to a profit $0.9. For the current year, the average estimate is a profit of $3.69, which is better than the estimate ninety days ago.
Here’s how Medtronic has been performing on an annual basis:
|Revenue ($) in millions||13,520||14,600||15,820||15,510||16,180|
|Diluted EPS ($)||1.95||1.84||2.79||2.86||3.41|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jan. 31, 2012||Apr. 30, 2012||Jul. 31, 2012||Oct. 31, 2012||Jan. 31, 2013|
|Revenue ($) in millions||3,918||4,297||4,008||4,095||4,027|
|Diluted EPS ($)||0.88||0.9462||0.83||0.63||0.97|
Medtronic has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)